Inventor · disambiguated record
Lorenz Waldmeier
Also filed as: WALDMEIER LORENZ
5 granted patents·7 pending applications·21 citations·filing 2016–2022
74Inventor score
Top patents by PatentIndex Score
12 records- 0196US11242388B2ROR1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2020·Granted Feb 8, 2022·8 cites·12 claims
- 0293US10618959B2ROR1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2018·Granted Apr 14, 2020·11 cites·26 claims
- 0382US11447546B2Human antibodies binding to ROR2NBE THERAPEUTICS AG·Filed 2018·Granted Sep 20, 2022·2 cites·5 claims
- 0470US2022153839A1Ror1 antibody compositions and related methodsNBE THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0566US12275789B2Human antibodies binding to ROR2NBE THERAPEUTICS AG·Filed 2022·Granted Apr 15, 2025·0 cites·9 claims
- 0655US2024100180A1Tumor-specific claudin 18.2 antibody-drug conjugatesSOTIO BIOTECH A S·Filed 2021·Application pending·0 cites
- 0751US2024034783A1Tumor-specific claudin 18.2 antibodiesSOTIO BIOTECH A S·Filed 2020·Application pending·0 cites
- 0851US2023030674A1Humanized cldn18.2 antibodiesSOTIO BIOTECH A S·Filed 2020·Application pending·0 cites
- 0951US2021379194A1Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological applicationsNBE THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 1047US2021139579A1Multispecific antibody product that binds to different ror1 epitopesNBE THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 1144US11845793B2Anti-ROR1 antibodiesNBE THERAPEUTICS AG·Filed 2016·Granted Dec 19, 2023·0 cites·8 claims
- 1236US2019112385A1Anti-mesothelin antibodiesNBE THERAPEUTICS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lorenz Waldmeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →